Soluble triggering receptor expressed on myeloid cells 1 (sTREM-1) has emerged as a biomarker, amplifying the immune response in sepsis and linking innate immunity activation to the systemic inflammation characteristic of this condition. This evidence concerns the gene TREM1 and Sepsis.